Effect of elastase on primary graft patency after femoralpopliteal arterial bypass for arteriosclerosis obliterans: A randomized, controlled study

International Surgery

Volumn 82, Issue 1, 1997, Pages 94-97

  Fujioka, K ^a   Esato, K ^a   Zempo, N ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Elastase; Femoralpopliteal bypass; Patency rate

Indexed keywords

ANTITHROMBOCYTIC AGENT; ELASTASE; PANCREATIC ELASTASE;

AGED; ARTERY BYPASS; ARTERY RECONSTRUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT PATENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN;

AGED; ARTERIOSCLEROSIS OBLITERANS; BLOOD VESSEL PROSTHESIS; DRUG THERAPY, COMBINATION; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PANCREATIC ELASTASE; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; SAPHENOUS VEIN; TRANSPLANTATION, AUTOLOGOUS; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 0030956048     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Imparato AM, Bracco A, Kim GE, Zeff R. Intimal and neointimal fibrous proliferation causing failure of arterial reconstruction. Surgery 1972;72:1007-1017.
2. Szilagyi DE, Elliott JP, Hageman JH et al. Biologic fate of autogenous vein implants as arterial substitutes. Ann Surg 1973; 178:232-246.
3. 2 analogue TRK-100 on the suppression of intimal fibrous proliferation. J Vasc Surg 1992;16:232-238.
4. McCready RA, Price MA, Kryscio RJ. Failure of antiplatelet therapy with ibuprofen (Motrin) to prevent neointimal fibrous hyperplasia. J Vasc Surg 1985;2:205-213.
5. Majesky MW, Schwartz SM, Clowed MM, Clowes AW. Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res 1987;61:296-300.
6. Baló J, Banga I. Change in the elastase content of the human pancreas in relation to arteriosclerosis. Acta Physiol Acad Sci Hung 1953;4:187-194.
7. O-hara M, Esato K, Mohri H. Effect of pancreatopeptidase (Elastase) on the suppression of intimal fibrous proliferation. J Cardiovasc Surg 1987;28:1-8.
8. Greenwood M. The natural duration of cancer reports on Public Health and Medical Subjects. (London: His Majesty's Stationery Office, 1926), No. 33.
9. Clowes AW. The role of aspirin in enhancing arterial graft patency. J Vasc Surg 1986;3:381-388.
10. Clagett GP. Clinical trials on antithrombotic therapy in patients undergoing lower extremity bypass: Current status and recommendations. J Vasc Surg 1991;13:761-763.
11. Dormandy J. Surgical pharmacotherapy. Eur J Vasc Surg 1989; 3:379-380.
12. McCollum C, Kenchigton G, Alexander C et al. PTFE of HUV for femoro-popliteal bypass: A multicentre trial. Eur J Vasc Surg 1991;5:435-443.
13. Powell JT. The patient's contribution to graft patency. In: Greenhalgh RM, Hollier LH, editors. The maintenance of arterial reconstruction. London: WB Saunders, 1990:87-93.
14. Yoshimura S, Hasegawa M, Yabe K. Pulse wave and arterial elastic property - The principle and essence of the pulse wave velocity method. Resp Circ 1976;24:376-387 (in Japanese).
15. Green RM, Roedersheimer R, DeWeese JA et al. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery 1982;92:1016-1026.
16. Chsebro JH, Clements IP, Fuster V et al. A platelet-inhibitor-drug trial in coronary-artery bypass operation. N Engl J Med 1982; 307:73-78.
17. Kohler TR, Kaufman JL, Kacoynis G et al. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery 1984;96:462-466.
18. Sarin S, Shami SK, Cheatle TR et al. When do vascular surgeons prescribe antiplatelet therapy? Current attitudes. Eur J Vasc Surg 1993;7:6-13.